Skip to main content

Pranab Das, MD

08/01/2008
Technological advancements have revolutionized the field of interventional cardiology by introducing newer devices and better pharmacological agents. The incidence of cardiogenic shock (CS) complicating acute myocardial infarction (AMI)...
Technological advancements have revolutionized the field of interventional cardiology by introducing newer devices and better pharmacological agents. The incidence of cardiogenic shock (CS) complicating acute myocardial infarction (AMI)...
Technological advancements have...
08/01/2008
Journal of Invasive Cardiology
Commentary
09/10/2008
Adequate stent deployment is one of the most important technical factors during percutaneous coronary intervention. Inadequate stent expansion or apposition allows a nidus for stent thrombosis and in-stent restenosis. The factors affecting...
Adequate stent deployment is one of the most important technical factors during percutaneous coronary intervention. Inadequate stent expansion or apposition allows a nidus for stent thrombosis and in-stent restenosis. The factors affecting...
Adequate stent deployment is one...
09/10/2008
Journal of Invasive Cardiology
Commentary
10/08/2008
Since the approval of the drug-eluting stents (DES) in April of 2003 by the U.S. Food and Drug Administration (FDA) and a year earlier in Europe, the rise of DES had been phenomenal, a feat rarely seen in contemporary medicine. With much...
Since the approval of the drug-eluting stents (DES) in April of 2003 by the U.S. Food and Drug Administration (FDA) and a year earlier in Europe, the rise of DES had been phenomenal, a feat rarely seen in contemporary medicine. With much...
Since the approval of the...
10/08/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Several randomized trials have demonstrated the efficacy of drug-eluting stents (DES) in reducing restenosis and the need for target vessel revascularization (TVR) in comparison to bare metal stents (BMS).1-3 Patient and lesion subsets...
Several randomized trials have demonstrated the efficacy of drug-eluting stents (DES) in reducing restenosis and the need for target vessel revascularization (TVR) in comparison to bare metal stents (BMS).1-3 Patient and lesion subsets...
Several randomized trials have...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
11/06/2009
TITLE: Long-Term Outcomes of Plaque Debulking with Rotational Atherectomy in Side-Branch Ostial Lesions to Treat Bifurcation Coronary Disease ABSTRACT: Background. The prognosis after rotational atherectomy of a side-branch ostium to treat...
TITLE: Long-Term Outcomes of Plaque Debulking with Rotational Atherectomy in Side-Branch Ostial Lesions to Treat Bifurcation Coronary Disease ABSTRACT: Background. The prognosis after rotational atherectomy of a side-branch ostium to treat...
TITLE: Long-Term Outcomes of...
11/06/2009
Journal of Invasive Cardiology